HTR1E

5-hydroxytryptamine receptor 1E, the group of 5-hydroxytryptamine receptors, G protein-coupled

Basic information

Region (hg38): 6:86937528-87016679

Links

ENSG00000168830NCBI:3354OMIM:182132HGNC:5291Uniprot:P28566AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

No genCC data.

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the HTR1E gene.

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the HTR1E gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
1
clinvar
1
clinvar
2
missense
17
clinvar
2
clinvar
19
nonsense
0
start loss
0
frameshift
0
inframe indel
0
splice donor/acceptor (+/-2bp)
0
splice region
0
non coding
0
Total 0 0 17 3 1

Variants in HTR1E

This is a list of pathogenic ClinVar variants found in the HTR1E region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
6-87015389-A-G not specified Uncertain significance (Sep 17, 2021)2251058
6-87015577-C-G not specified Likely benign (Sep 12, 2023)2595326
6-87015670-C-T Likely benign (Apr 10, 2018)721535
6-87015725-G-A not specified Uncertain significance (Dec 15, 2022)2335281
6-87015738-C-T not specified Uncertain significance (Nov 03, 2023)3107491
6-87015753-C-T not specified Uncertain significance (Apr 06, 2023)2519478
6-87015824-C-T not specified Uncertain significance (Oct 14, 2023)3107492
6-87015904-G-A Benign (Mar 29, 2018)727832
6-87015945-G-A not specified Uncertain significance (Aug 20, 2023)2594390
6-87016032-T-C not specified Uncertain significance (Dec 09, 2024)3527087
6-87016058-T-C not specified Uncertain significance (Aug 02, 2023)2615094
6-87016089-C-G not specified Uncertain significance (Mar 24, 2023)2509865
6-87016110-T-C not specified Uncertain significance (Feb 12, 2024)3107493
6-87016133-C-A not specified Uncertain significance (Jul 16, 2024)3527086
6-87016133-C-G not specified Uncertain significance (Dec 13, 2022)2334525
6-87016134-C-A Likely benign (Feb 08, 2018)723586
6-87016170-A-G not specified Uncertain significance (Feb 16, 2023)2485849
6-87016221-T-C not specified Uncertain significance (Sep 17, 2021)2251264
6-87016295-G-A not specified Uncertain significance (Aug 16, 2021)2245801
6-87016331-G-A not specified Uncertain significance (Jan 23, 2023)3107494
6-87016422-A-C not specified Uncertain significance (May 16, 2024)3285026

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
HTR1Eprotein_codingprotein_codingENST00000305344 179326
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
0.2930.6881257260221257480.0000875
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense1.711452160.6720.00001262399
Missense in Polyphen56100.530.557041108
Synonymous0.1208788.40.9840.00000547753
Loss of Function1.9828.090.2473.43e-7106

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.0001810.000181
Ashkenazi Jewish0.0001980.000198
East Asian0.00005440.0000544
Finnish0.000.00
European (Non-Finnish)0.0001230.000123
Middle Eastern0.00005440.0000544
South Asian0.000.00
Other0.0001660.000163

dbNSFP

Source: dbNSFP

Function
FUNCTION: G-protein coupled receptor for 5-hydroxytryptamine (serotonin). Also functions as a receptor for various alkaloids and psychoactive substances. Ligand binding causes a conformation change that triggers signaling via guanine nucleotide-binding proteins (G proteins) and modulates the activity of down-stream effectors, such as adenylate cyclase. Signaling inhibits adenylate cyclase activity. {ECO:0000269|PubMed:14744596, ECO:0000269|PubMed:1513320, ECO:0000269|PubMed:1608964, ECO:0000269|PubMed:1733778, ECO:0000269|PubMed:21422162}.;
Pathway
Serotonergic synapse - Homo sapiens (human);cAMP signaling pathway - Homo sapiens (human);Neuroactive ligand-receptor interaction - Homo sapiens (human);Taste transduction - Homo sapiens (human);Selective Serotonin Reuptake Inhibitor Pathway, Pharmacodynamics;GPCRs, Class A Rhodopsin-like;Monoamine GPCRs;Serotonin HTR1 Group and FOS Pathway;Signaling by GPCR;Signal Transduction;Serotonin receptors;Amine ligand-binding receptors;Class A/1 (Rhodopsin-like receptors);GPCR ligand binding;G alpha (i) signalling events;GPCR downstream signalling (Consensus)

Recessive Scores

pRec
0.119

Intolerance Scores

loftool
0.580
rvis_EVS
-0.47
rvis_percentile_EVS
23.25

Haploinsufficiency Scores

pHI
0.248
hipred
Y
hipred_score
0.501
ghis
0.582

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
N
essential_gene_gene_trap
N
gene_indispensability_pred
E
gene_indispensability_score
0.940

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Gene ontology

Biological process
G protein-coupled receptor signaling pathway;G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger;adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway;chemical synaptic transmission;G protein-coupled serotonin receptor signaling pathway
Cellular component
plasma membrane;integral component of plasma membrane;dendrite
Molecular function
G protein-coupled receptor activity;G protein-coupled serotonin receptor activity;protein binding;neurotransmitter receptor activity;serotonin binding